ANIX·03528H109·US·equity·Healthcare - Biotechnology-Activist
ANIX (ANIXA BIOSCIENCES INC) is held by 35 institutional investors as of Q1 2026. Largest holders: UBS Group AG ($1.4M), D.A. DAVIDSON & CO. ($1.4M), GEODE CAPITAL MANAGEMENT, LLC ($941,440). Net institutional sentiment: Mixed.
See how ANIX's score breaks down across 4 SEC sources
Showing 1-20 of 46
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer